Increasing the gonadotrophin dose in the course of an in vitro fertilization cycle does not rectify an initial poor response

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 103, Issue 2, 2002, Pages 146-149

  Khalaf, Y ^a   El Toukhy, Tarek ^a   Taylor, A ^a   Braude, P ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Gonadotrophin dose; Low responders; Ovarian stimulation

Indexed keywords

BUSERELIN; HUMAN MENOPAUSAL GONADOTROPIN; UROFOLLITROPIN; ESTRADIOL;

ADULT; ARTICLE; DOSE RESPONSE; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; INFERTILITY; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; OOCYTE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; BLOOD; METHODOLOGY; OVULATION INDUCTION; PHYSIOLOGY; PREGNANCY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; HUMANS; MENOTROPINS; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0037054717     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(02)00036-2     Document Type: Article

References (24)

1. Evaluation and treatment of low responders
2. Low serum estradiol concentrations after 5 days of controlled ovarian hyperstimulation for in-vitro fertilization are associated with poor outcome
3. A comparison of two starting doses of human menopausal gonadotrophin for follicle stimulation in unselected patients for in-vitro fertilization
4. The importance of follicular phase to success and failure in in-vitro fertilization
5. The association between pre-ovulatory serum 17-β estradiol pattern and conception in human menopausal gonadotrophin-human chorionic gonadotrophin stimulation
6. IVF: induction of ovulation in poor responders
7. Doubling the human menopausal gonadotropin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study
8. The need to step up the gonadotropin dosage in the stimulation phase of IVF treatment predicts a poor outcome
9. Folliculogenesis-the stimulated way
10. A model for follicular selection and ovulation: lessons for superovulation
11. Hormonal actions during maturation influence fertilization and early embryonic development
12. The micro-environment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells and the status of the oocyte in-vivo and in-vitro
13. The predictive value and the management of cycles with low initial estradiol levels
14. Superovulation with a high gonadotropin dose for in vitro fertilization: is it effective?
15. High dose FSH stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low responder patients
16. Increasing the human menopausal gonadotropin dose-does the response really improve?
17. High-dose human menopausal gonadotrophin stimulation in poor responders does not improve in-vitro fertilization outcome
18. Dose of human menopausal gonadotrophin influences the outcome of an in-vitro fertilization program
19. Effect of high time levels of luteinizing hormone on outcome of in-vitro fertilization
20. Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocyte after ovarian stimulation
21. Hypersecretion of luteinizing hormone, infertility and miscarriage
22. High dosage of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer
23. Addition of GnRH antagonist in cycles of poor responders undergoing IVF